Pharmacology and therapeutics of ezetimibe (SCH 58235), a cholesterol-absorption inhibitor

This publication has 67 references indexed in Scilit:

• Inhibition of cholesterol absorption by SCH 58053 in the mouse is not mediated via changes in the expression of mRNA for ABCA1, ABCG5, or ABCG8 in the enterocyte
  Journal of Lipid Research, 2002
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
  Published by Elsevier ,2002
• Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up
  The Lancet, 2002
• Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
  JAMA, 2001
• Follow-up study of patients randomized in the scandinavian simvastatin survival study (4S) of cholesterol lowering
  The American Journal of Cardiology, 2000
• Treatment of hyperlipidemia with combined niacin–statin regimens
  The American Journal of Cardiology, 1998
• Mechanistic studies of high-density lipoproteins
  The American Journal of Cardiology, 1998
• Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
  New England Journal of Medicine, 1998
• Efficacy and safety of Simvastatin 80 mg/day in hypercholesterolemic patients
  The American Journal of Cardiology, 1998
• Ten-Year Mortality from Cardiovascular Disease in Relation to Cholesterol Level among Men with and without Preexisting Cardiovascular Disease
  New England Journal of Medicine, 1990